...
首页> 外文期刊>Frontiers in bioscience: a journal and virtual library >Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer.
【24h】

Potential applications of miRNAs as diagnostic and prognostic markers in liver cancer.

机译:miRNA在肝癌中作为诊断和预后标志物的潜在应用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Primary liver tumors are mainly represented by hepatocellular hepatocarcinoma (HCC), one of the most aggressive and resistant forms of cancer. Numerous studies have reported the key role of microRNAs (miRNAs) in development, cell proliferation, apoptosis, and tumor biology. The alteration of cancer-related miRNA expression can be associated with tumorigenesis. In HCC, deregulated miRNAs frequently act as oncogenes or altered tumor suppressors. Distinct subtypes of hepatic cancer can also be related to an aberrant expression of particular miRNAs, arguing for the significance of using miRNAs as tumor biomarkers in order to refine the HCC grading assessment. In this article, we review the latest reports regarding miRNA profiling and the potential of small RNAs in HCC diagnosis. The relevance of cancer-related miRNA signatures for the prognosis and better understanding of liver cancer outcome is then considered.
机译:原发性肝肿瘤主要表现为肝细胞性肝癌(HCC),这是最具攻击性和耐药性的癌症形式之一。大量研究报告了microRNA(miRNA)在发育,细胞增殖,凋亡和肿瘤生物学中的关键作用。癌症相关miRNA表达的改变可能与肿瘤发生有关。在HCC中,失调的miRNA通常充当癌基因或改变的肿瘤抑制因子。肝癌的不同亚型也可能与特定miRNA的异常表达有关,这证明了将miRNA用作肿瘤生物标志物以改善HCC分级评估的重要性。在本文中,我们回顾了有关miRNA分析和小RNA在HCC诊断中的潜力的最新报告。然后考虑与癌症相关的miRNA签名与预后和对肝癌预后的更好了解之间的相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号